Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.
Ontology highlight
ABSTRACT: Neurofibromatosis type 1 (NF1) and schwannomatosis (SWN) are rare genetic disorders with distinct genetic etiologies. Both syndromes are predominantly characterized by the development of multiple benign nerve sheath tumors, which typically arise from cranial/peripheral nerves. The management of NF1/SWN-associated benign nerve sheath tumors pose a substantial clinical challenge. In recent years, immunotherapy has demonstrated significant efficacy in treating various tumors, but its application to NF1/SWN has not been explored. In this study, we first evaluated the feasibility of chimeric antigen receptor (CAR)-T cell therapy for the treatment of benign NF1/SWN-related nerve sheath tumor by analyzing the expression of multiple antigens in 85 tumor samples. Our findings revealed that epiderma
SUBMITTER: Tang N
PROVIDER: S-EPMC11871713 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA